Inhibition of JAK/STAT pathway by demethylation treatment or by applying specific JAK2 inhibitor may open up a new therapeutic strategy against gastric cancer (De Vos et al, 2000; Burke et al, 2001; Yoshikawa et al, 2001). Here, JAK2 is linked to gastric cancer.